Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid
Study population We included all patients registered as having type 2 diabetes in the National Diabetes Register who filled their first prescription for a GLP-1 receptor agonist, and, in a separate cohort, all patients registered as having type 2 diabetes in the National Diabetes Register who filled their first prescription for an SGLT2 inhibitor, between 1 January 2017 and 31 December 2021 (ensuring a minimum of 1-year follow-up until the end of the study period on 31 December 2022)
Frecuencia : Aplicar 2 veces/da , con al menos 6 horas de diferencia , durante un mnimo de 28 das para obtener resultados medibles
The demonstrated activity of PYC against viruses, such as HCV, DENV, and SARS-CoV-2, highlights its broad-spectrum therapeutic potential
It has a tremendous ability to fight oxidative stress and neutralise harmful free radicals (hence the name free radical scavenger")